Positive PD-L1 Expression Is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with EGFR-TKIs

被引：0
|
作者：
Lee, S. H. [1 ]
Park, M. J. [1 ]
Chang, B. [1 ]
机构：
[1] Kyung Hee Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
EGFR-TKIs; programmed death ligand; Clinical outcome;
D O I：
10.1016/j.jtho.2019.08.1195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.14-44
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [1] Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs
    Lee, Seung Hyeun
    Park, Myung Jae
    Chang, Boksoon
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Positive PD-L1 Expression Is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with EGFR-TKIs
    Jeon, W.
    Lim, B.
    Han, S.
    Kwack, W.
    Chang, B.
    Choi, H.
    Kim, Y.
    Choi, C.
    Park, M.
    Yoo, J.
    Lee, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
    Yoon, Byung Woo
    Chang, Boksoon
    Lee, Seung Hyeun
    ONCOTARGETS AND THERAPY, 2020, 13 : 8273 - 8285
  • [4] High PD-L1 Expression is Aassociated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
    Lee, S. H.
    Chang, B.
    Yoon, B. W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S611 - S612
  • [5] Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression
    Kobayashi, Kenichi
    Seike, Masahiro
    Zou, Fenfei
    Noro, Rintaro
    Chiba, Mika
    Ishikawa, Arimi
    Kunugi, Shinobu
    Kubota, Kaoru
    Gemma, Akihiko
    ANTICANCER RESEARCH, 2018, 38 (02) : 753 - 762
  • [6] Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma
    Slomka, Jeremy
    Berthou, Hugo
    Mansuet-Lupo, Audrey
    Blons, Helene
    Fabre, Elizabeth
    Lerner, Ivan
    Rance, Bastien
    Alifano, Marco
    Chapron, Jeanne
    Birsen, Gary
    Gibault, Laure
    Arrondeau, Jennifer
    Leroy, Karen
    Wislez, Marie
    PLOS ONE, 2024, 19 (11):
  • [7] Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated with EGFR-TKIs
    Kim, I. A.
    Kim, H. J.
    Lee, J. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2138 - S2138
  • [8] PD-L1 Induced Resistance to EGFR-TKIs in Lung Adenocarcinoma
    Yi, G.
    Zhang, X.
    Li, S.
    Liu, L.
    Yuan, P.
    Yang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S629 - S629
  • [9] PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs
    Bai, Yuchen
    Chen, Xiaoxia
    Hou, Likun
    Qian, Jun
    Jiang, Tao
    Zhou, Caicun
    Ciebiada, Maciej
    CANCER BIOLOGY & MEDICINE, 2018, 15 (04) : 434 - +
  • [10] PD-L1 expression and its effect on clinical outcomes of EGFRmutant NSCLC patients treated with EGFR-TKIs
    Yuchen Bai
    Xiaoxia Chen
    Likun Hou
    Jun Qian
    Tao Jiang
    Caicun Zhou
    Maciej Ciebiada
    Cancer Biology & Medicine, 2018, 15 (04) : 434 - 442
12345